Bruker Corporation - stock earnings

BRKR Upcoming estimated earnings

DateLow RevenueAverage RevenueHigh Revenue
May 2, 2024 BeforeMarket 717.0 million 729.8 million 742.1 million

BRKR Quarterly earnings

DateEarningsRevenue
2023Q4 205.5 million USD 854.5 million USD
2023Q3 88.1 million USD 742.8 million USD
2023Q2 57.1 million USD 681.9 million USD
2023Q1 76.5 million USD 685.3 million USD
2022Q4 97.4 million USD 708.4 million USD
2022Q3 88.1 million USD 638.9 million USD
2022Q2 49.5 million USD 588.4 million USD
2022Q1 61.6 million USD 595.0 million USD
2021Q4 75.7 million USD 683.5 million USD
2021Q3 87.1 million USD 608.9 million USD
2021Q2 57.6 million USD 570.8 million USD
2021Q1 56.7 million USD 554.7 million USD
2020Q4 68.9 million USD 627.5 million USD
2020Q3 54.3 million USD 511.4 million USD
2020Q2 24.1 million USD 424.6 million USD
2020Q1 10.5 million USD 424.0 million USD
2019Q4 68.6 million USD 599.9 million USD
2019Q3 61.3 million USD 521.1 million USD
2019Q2 36.5 million USD 490.2 million USD
2019Q1 30.8 million USD 461.4 million USD
2018Q4 78.1 million USD 553.6 million USD
2018Q3 43.4 million USD 466.6 million USD
2018Q2 31.2 million USD 443.7 million USD
2018Q1 27.0 million USD 431.7 million USD
2017Q4 -3.4 million USD 530.5 million USD
2017Q3 37.0 million USD 435.6 million USD
2017Q2 23.4 million USD 414.9 million USD
2017Q1 21.6 million USD 384.9 million USD
2016Q4 69.0 million USD 470.3 million USD
2016Q3 46.5 million USD 393.9 million USD
2016Q2 14.5 million USD 371.7 million USD
2016Q1 23.6 million USD 375.4 million USD
2015Q4 61.4 million USD 478.2 million USD
2015Q3 11.8 million USD 396.1 million USD
2015Q2 21.9 million USD 396.0 million USD
2015Q1 6.5 million USD 353.5 million USD
2014Q4 26.1 million USD 508.0 million USD
2014Q3 5.5 million USD 419.8 million USD
2014Q2 16.4 million USD 457.4 million USD
2014Q1 8.7 million USD 423.7 million USD
2013Q4 35.2 million USD 552.1 million USD
2013Q3 16.6 million USD 439.0 million USD
2013Q2 22.9 million USD 454.9 million USD
2013Q1 5.4 million USD 393.4 million USD
2012Q4 12.8 million USD 517.3 million USD
2012Q3 39.7 million USD 447.8 million USD
2012Q2 9.9 million USD 420.7 million USD
2012Q1 15.1 million USD 405.6 million USD
2011Q4 39.1 million USD 475.1 million USD
2011Q3 19.8 million USD 418.4 million USD
2011Q2 22.1 million USD 401.2 million USD
2011Q1 11.3 million USD 357.0 million USD
2010Q4 29.3 million USD 416.1 million USD
2010Q3 27.4 million USD 310.2 million USD
2010Q2 22.6 million USD 300.9 million USD
2010Q1 16.1 million USD 277.7 million USD
2009Q4 43.5 million USD 366.4 million USD
2009Q3 16.4 million USD 265.1 million USD
2009Q2 12.7 million USD 252.5 million USD
2009Q1 8.6 million USD 230.5 million USD
2008Q4 26.1 million USD 315.1 million USD
2008Q3 17.8 million USD 242.1 million USD
2008Q2 21.7 million USD 311.6 million USD
2008Q1 -685000 USD 238.4 million USD
2007Q4 14.0 million USD 183.7 million USD
2007Q3 8.7 million USD 131.6 million USD
2007Q2 5.0 million USD 121.7 million USD
2007Q1 3.9 million USD 110.5 million USD
2006Q4 9.7 million USD 135.6 million USD
2006Q3 3.0 million USD 104.9 million USD
2006Q2 480000 USD 77.8 million USD
2006Q1 776000 USD 74.4 million USD
2005Q4 1.9 million USD 80.6 million USD
2005Q3 1.1 million USD 70.7 million USD
2005Q2 284000 USD 71.4 million USD
2005Q1 417000 USD 74.9 million USD
2004Q4 -1.5 million USD 85.6 million USD
2004Q3 -2.7 million USD 66.5 million USD
2004Q2 -4.7 million USD 64.1 million USD
2004Q1 1.0 million USD 68.2 million USD
2003Q4 310000 USD 73.7 million USD
2003Q3 -14.7 million USD 63.1 million USD
2003Q2 -233000 USD 34.4 million USD
2003Q1 -1.1 million USD 34.1 million USD
2002Q4 -4.6 million USD 32.9 million USD
2002Q3 1.7 million USD 29.7 million USD
2002Q2 -4.2 million USD 27.9 million USD
2002Q1 941000 USD 25.8 million USD
2001Q4 934000 USD 24.7 million USD
2001Q3 925000 USD 23.8 million USD
2001Q2 833000 USD 22.3 million USD
2001Q1 945000 USD 21.9 million USD
2000Q4 1.2 million USD 21.8 million USD
2000Q3 633000 USD 22.7 million USD
2000Q2 213000 USD 17.5 million USD
2000Q1 174246 USD 14.6 million USD

BRKR Yearly earnings

DateEarningsRevenue
2023 427.2 million USD 3.0 billion USD
2022 296.6 million USD 2.5 billion USD
2021 277.1 million USD 2.4 billion USD
2020 157.8 million USD 2.0 billion USD
2019 197.2 million USD 2.1 billion USD
2018 179.7 million USD 1.9 billion USD
2017 78.6 million USD 1.8 billion USD
2016 153.6 million USD 1.6 billion USD
2015 101.6 million USD 1.6 billion USD
2014 56.7 million USD 1.8 billion USD
2013 80.1 million USD 1.8 billion USD
2012 77.5 million USD 1.8 billion USD
2011 92.3 million USD 1.7 billion USD
2010 95.4 million USD 1.3 billion USD
2009 81.2 million USD 1.1 billion USD
2008 64.9 million USD 1.1 billion USD
2007 31.5 million USD 547.6 million USD
2006 18.5 million USD 435.8 million USD
2005 3.6 million USD 297.6 million USD
2004 -7.8 million USD 284.4 million USD
2003 -17.6 million USD 260.7 million USD
2002 -6.2 million USD 116.4 million USD
2001 3.6 million USD 92.7 million USD
2000 2.3 million USD 76.6 million USD
1999 1.2 million USD 64.7 million USD
1998 ? USD 42.2 million USD

BRKR

Price: $82.46

52 week price:
53.79
94.86

Dividend Yield: 0.00%

5-year range yield:
0.00%
0.41%

Forward Dividend Yield: 0.24%

Payout Ratio: 9.26%

Payout Ratio Range:
6.90%
25.40%

Dividend Per Share: 0.20 USD

Earnings Per Share: 2.90 USD

P/E Ratio: 32.62

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Volume: 459000

Ebitda: 109.4 million

Market Capitalization: 12.5 billion

Average Dividend Frequency: 4

Years Paying Dividends: 9

DGR3: 8.83%

DGR5: 5.30%

Links: